Replies to post #399148 on NorthWest Biotherapeutics Inc (NWBO)

[jondoeuk]

But as I just answered ExW, your various research is not dispositive evidence of a lack of interest in many other technologies including DCVax.

Well, there are better selection and delivery methods than DCVax. For the former, GNCA's ATLAS https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.3107 https://cancerres.aacrjournals.org/content/80/16_Supplement/6680 https://cancerres.aacrjournals.org/content/81/13_Supplement/1762

As for the latter, GRTS is working on additional viral vectors and also further engineering them to co-express certain checkpoint inhibitors, T-cell co-stim agonists, and/or cytokines.

They will no doubt have their fingers in many pies and i doubt they will adopt technologies that do not have substantial evidence

Yet you still think MRK is interesting in NWBO's platform, despite the ORR for Direct being zero and an (still) unexplained FDA hold, buried IAs and the SAP change for -L, which should say it all!